Menu
PPD Blog
PPD Blog

Sharing industry knowledge as we
help deliver life-changing therapies.

 

FSP FSO Blog Thumb

Combining FSP and FSO Outsourcing Strategies

By Dave Agrella, vice president, functional service partnerships (FSP) and Timothy King, DrPH, executive director, FSP.

Read more...
 

AI ML Thumbnail

How artificial intelligence and machine learning will help us grow

Within pharmacovigilance at PPD, we have implemented various artificial intelligence and machine learning methods that help us and our clients achieve better results.

Read more...
 

Successful partnering in pharmacovigilance for clinical trials

Successful partnering in pharmacovigilance for clinical trials

Gary Barker, Denise Moody, Magda Santos and April Pierce provide insight into creating and keeping a successful pharmacovigilance partnership with a functional service provider.

Read more...
 

A practical guide for IMP supply chain planning post-Brexit

A practical guide for IMP supply chain planning post-Brexit

Brian Brogan, senior logistics manager, provides guidance for clinical trial supply chain requirements post-Brexit and offers some practical solutions for affected U.K.-based life science companies.

Read more...
 

Eligibility criteria in clinical trials - image of patient in hospital bed

Eligibility criteria in clinical trials

Giovanni Monopoli, senior project manager, reflects on what he learned about the eligibility criteria at an American Society of Clinical Oncology (ASCO) conference presentation in 2017.

Read more...
 

Woman with cancer and child - The challenges of immuno-oncology combined clinical development, Part IV

The challenges of immuno-oncology combined clinical development, Part IV

In the final of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Calendar planning holidays - Managing clinical studies through European holidays

Managing clinical studies through European holidays

PPD® Biotech’s Samantha Hadfield, senior director of project management, Helen Dunlop, director of project management, and Rania Laguel, director of project management, provide suggestions on preparing your study for the summer holidays in Europe.

Read more...
 

Cancer patient The challenges of immuno-oncology combined clinical development, Part III

The challenges of immuno-oncology clinical development, Part III

In the third of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Cancer patient with medical professional for the challenges of combination therapies in immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part II

In the second of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Challenges of immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part I

In the first of a four-part series, Jai Balkissoon, vice president of global product development, writes about the increase in immuno-oncology therapies.

Read more...
 

Local regulatory affiliates

The future of the local regulatory affiliate: Adjusting to global strategies, processes and expectations

Alistair Davidson, senior director, regulatory affairs, discusses the work of local regulatory affiliates.

Read more...
 

Lungs tuberculosis drug development

PPD’s fight against tuberculosis: Clinical trials with experienced teams

As we recognize World TB (tuberculosis) Day, PPD employees share their experiences working against the disease and their dedication to seek life-changing therapies for TB patients.

Read more...
 

Rare disease day 2018

The personal impact of rare diseases

PPD employees, including a rare disease patient, parent and researcher, share their experiences as we honor Rare Disease Day.

Read more...
 

Benefits of centralized monitoring in clinical trials

Benefits of centralized monitoring in clinical trials

Nicole Stansbury, executive director of adaptive and intelligent monitoring, answers questions about PPD’s clinical trial monitoring strategies.

Read more...
 

Infrastructure Design Is Key to Enhanced Clinical Trials Data Management thumbnail image

Infrastructure design is key to enhanced clinical trials data management

Brent Reed, director of information technology, writes about elements required for managing data for a successful clinical trial.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.